Get Real Time Here
| Open11.410 | Close11.220 |
| Vol / Avg.2.810M / 2.501M | Mkt Cap3.290B |
| Day Range11.190 - 11.480 | 52 Wk Range9.700 - 14.100 |
Amicus Therapeutics Stock (NASDAQ:FOLD), Quotes and News Summary
Amicus Therapeutics Stock (NASDAQ: FOLD) stock price, news, charts, stock research, profile.
| Open11.410 | Close11.220 |
| Vol / Avg.2.810M / 2.501M | Mkt Cap3.290B |
| Day Range11.190 - 11.480 | 52 Wk Range9.700 - 14.100 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.080 | -0.070 | 0.0100 | ||||
| REV | 101.360M | 103.501M | 2.141M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-09 | Morgan Stanley | Andrew Galler | Maintains | Equal-WeightEqual-Weight | Raises | 14.00 | 15.00 |
| 2023-10-10 | Morgan Stanley | Andrew Galler | Maintains | Equal-WeightEqual-Weight | Lowers | 15.00 | 14.00 |
| 2023-09-29 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Raises | 17.00 | 19.00 |
| 2023-07-11 | Morgan Stanley | Andrew Galler | Reiterates | Equal-WeightEqual-Weight | Maintains | 15.00 | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| FOLD | Amicus Therapeutics | -2.18% | 3.3B |
| RARE | Ultragenyx Pharmaceutical | -2.32% | 3.3B |
| MLTX | MoonLake | 2.39% | 3.4B |
| ALKS | Alkermes | -1.15% | 4.3B |
| MRTX | Mirati Therapeutics | -0.35% | 4B |
How do I buy Amicus Therapeutics (FOLD) stock?
You can purchase shares of Amicus Therapeutics (NASDAQ: FOLD) through any online brokerage.
Who are Amicus Therapeutics's (FOLD) competitors?
Other companies in Amicus Therapeutics’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS), Mirati Therapeutics (NASDAQ:MRTX) and Vaxcyte (NASDAQ:PCVX).
What is the target price for Amicus Therapeutics (FOLD) stock?
The latest price target for Amicus Therapeutics (NASDAQ: FOLD) was reported by Morgan Stanley on Thursday, November 9, 2023. The analyst firm set a price target for 15.00 expecting FOLD to rise to within 12 months (a possible 33.69% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Amicus Therapeutics (FOLD)?
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $11.22 last updated December 8, 2023 at 9:20 PM UTC.
Does Amicus Therapeutics (FOLD) pay a dividend?
There is no dividend information for Amicus Therapeutics.
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics’s Q4 earnings are confirmed for Wednesday, February 28, 2024.
Is Amicus Therapeutics (FOLD) going to split?
There is no upcoming split for Amicus Therapeutics.
What sector and industry does Amicus Therapeutics (FOLD) operate in?
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.